OrderlyMeds review

Choose a clinical purpose before a broader menu

OrderlyMeds offers weight-care prescriptions, with NAD+ and sermorelin in a longevity category. The latter two are restricted to existing customers purchasing a GLP-1 refill. That establishes conditional product access, not a reason to combine prescriptions or begin GLP-1 treatment to qualify. ^{[1] [2] [3]}

The healthspan question is what useful decision a service supports. Weight management, hormone-related assessment and a general wish for more energy are different starting points. A shared portal cannot replace a separate clinical purpose and evidence review for each proposed intervention.

Compare the defined service in our health-service comparisons.

Keep the required base bill beside an add-on

NAD+ costs $224 for one month or $448 for two; sermorelin costs $200 or $400. Each requires an existing customer’s matching GLP-1 refill, which is additional. These figures are not one inclusive health program or a complete combined-care price. ^{[2] [3]}

Regular compounded semaglutide and tirzepatide rates are $149 and $299 monthly. Starter and transfer packages have distinct two-month totals, while current eligibility wording conflicts. Confirm the product, paid term and total selected charge before treating any advertised equivalent as the cost of continuing care. ^{[4] [5] [6]}

Separate each commitment in the complete care-cost planner.

Identify who is responsible for follow-up

The terms distinguish the OrderlyMeds platform from its medical provider and describe a nonclinical administrative role for CareValidate. The current FAQ names a broader pharmacy network than the older terms. Obtain the actual practice, prescriber and dispenser for the selected treatment. ^{[7] [8]}

The service does not require routine bloodwork to begin, although clinicians may recommend it. This is an access policy, not evidence that no assessment is needed. Coordinate the plan with existing care and establish what follow-up or additional testing will actually be provided. ^[7]

For another focused prescription-care model, read our Nurx review.

Match evidence to the preparation and outcome

The NAD+ page describes a cellular coenzyme and the sermorelin page discusses endocrine signaling. Neither explanation establishes improved function, fewer clinical events or longer healthy life from these compounded injections. A combination sold at refill requires its own justification. ^{[2] [3]}

FDA distinguishes compounds from approved products and recommends compounded GLP-1 medicines only for medical needs an approved drug cannot meet. Brand-trial outcomes and pharmacy-standard badges cannot establish the effectiveness of a different finished preparation or its healthspan benefit. ^{[10] [11]}

Keep the actual medicine and population attached to the SELECT cardiovascular evidence.

Distinguish measured outcomes with lean mass and physical function.

Testing and support offers have their own limits

The partner page advertises biomarker testing from $75, a $49 nutrition product, one free month of BetterHelp, fitness-app access and a discounted first meal order. These are separate offers for active patients, not an unlimited included preventive program. ^[9]

Consider what an additional test would change and who would interpret or act on it. A larger panel is not automatically more useful care. Likewise, a temporary free benefit should be evaluated for its actual duration, subsequent cost and overlap with support already available to you.

For a different testing and medication package, compare our Noom Proactive Health review.

Review the financial exit alongside continuity

The FAQ describes customer-requested refill billing without a required subscription. Payment precedes clinical approval; ineligibility receives a refund, but the ordinary cancellation window closes when a prescription is written. Multi-month plans have a separate qualification that needs resolution before payment. ^[7]

I would compare the service on a defined prescription, complete bill and workable clinical follow-up. Clarify possible taxes or delivery exceptions in the general terms and the treatment of unused prepaid supply. The attraction should be a useful addition to care, rather than an advertised collection of longevity products. ^[8]

For another broad catalogue and care arrangement, see our Raeliva review.

For a separate NAD+ and metabolic prescription offering, read our Peak Wellness review.

Understanding the cost

Regular compounded semaglutide $149/month and tirzepatide $299/month; introductory terms vary and require confirmation. Existing refill customers may add NAD+ for $224/$448 or sermorelin for $200/$400 for one/two months, on top of the matching GLP-1 refill. Partner biomarker testing starts at $75; this is not a complete preventive-care total. ^{[2] [3] [4] [5] [6] [7] [8] [9]}